Press Releases about Astrazeneca Plc ADR![]()
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
April 18, 2024
Via AB Newswire
Topics
Economy
Exposures
Interest Rates
![]() ![]() From AstraZeneca
Via Business Wire
![]() ![]() ![]() ![]() ![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]()
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
March 26, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]() ![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AstraZeneca Full year and Q4 2023 Financial Results
February 08, 2024
From AstraZeneca
Via Business Wire
![]() ![]()
Markets suddenly price Eli Lilly stock for a breakout on earnings
February 05, 2024
Via MarketBeat
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|